Secondary outcome measures

CN Claire M Nolan
SP Suhani Patel
RB Ruth E Barker
JW Jessica A Walsh
OP Oliver Polgar
MM Matthew Maddocks
PG Peter M George
ER Elisabetta A Renzoni
AW Athol U Wells
PM Philip L Molyneaux
VK Vasilis Kouranos
FC Felix Chua
TM Toby M Maher
WM William D-C Man
request Request a Protocol
ask Ask a question
Favorite

The secondary outcome measures were those that had the potential to be primary or secondary outcomes in a definitive clinical trial. These were: exercise capacity (6 min walk test),17 functional performance (Short Physical Performance Battery),18 4 m gait speed,19 rectus femoris size (ultrasound of rectus femoris cross-sectional area (Mindray DP-50, Caiyside Imaging, Scotland)), quadriceps strength (isometric QMVC),20 health-related quality of life (King’s Brief Interstitial Lung Disease questionnaire),21 activities of daily living (London Chest Activities of Daily Living questionnaire)22 and physical activity parameters (daily step count, time spent sedentary, light and moderate-intensity activity (SenseWear, BodyMedia, USA)).23

Following the 12-week assessment, purposively sampled participants were invited to take part in semistructured, topic-guided, telephone-based interviews. The audio-recorded interviews explored experiences of the intervention, how it impacted perceptions of outcome, acceptability of outcome measures and trial conduct in order to inform the rationale for and conduct of a definitive trial. The topic guides were updated inductively to reflect experiences and perceptions raised during previous interviews.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A